SCHEMBL7992360

SCHEMBL7992360

NC(=O)c1c(N)ncn1CCCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.46
CNOT7 Q9UIV1 2/20 0.45
TSHR P16473 2/20 0.45
LMNA P02545 2/20 0.43
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
ADORA2A P29274 3/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
SIGMAR1 Q99720 2/20 0.40
PARP1 P09874 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
CFTR P13569 1/20 0.40
FAAH O00519 1/20 0.40
CES1 P23141 1/20 0.40
HTT P42858 1/20 0.39
HDAC3 O15379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988810 0.92 ADORA2A (0.51) ADRA1DCNOT7TSHRADORA2AMEN1
SCHEMBL5483136 0.82 PKM (0.59) ADRA1DTSHRLMNAADORA2AGAA
SCHEMBL7973752 0.82 SMN1; SMN2 (0.47) TSHRLMNAMAPK1KDM4EMEN1
Hydrochloric Acid SCHEMBL7987445 0.81 PKM (0.57) ADRA1DTSHRLMNAADORA2AGAA
SCHEMBL7984506 0.79 EHMT2 (0.43) ADRA1DCNOT7TSHRADORA2AGAA
SCHEMBL7974138 0.78 KMT2A (0.52) ADRA1DCNOT7TSHRLMNAMAPK1
SCHEMBL7974495 0.78 ADORA2A (0.48) LMNAPOLBADORA2AMEN1KMT2A
SCHEMBL7988146 0.78 GAA (0.51) CNOT7TSHRLMNAMAPK1MEN1
SCHEMBL31333072 0.77 ADRA1D (0.48) ADRA1DCNOT7TSHRLMNAMAPK1
Hydrochloric Acid SCHEMBL7984737 0.77 ADORA2A (0.47) LMNAPOLBADORA2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed